metformin has been researched along with Sexual Dysfunction, Physiological in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Sexual Dysfunction, Physiological: Physiological disturbances in normal sexual performance in either the male or the female.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Men with type 2 diabetes (T2D) and obesity are often characterised by low testosterone (T)." | 5.48 | Short-term combined treatment with exenatide and metformin is superior to glimepiride combined metformin in improvement of serum testosterone levels in type 2 diabetic patients with obesity. ( Hao, M; Kuang, HY; Li, BW; Ma, XF; Pan, J; Shao, N; Wu, WH; Yu, XY; Yu, YM; Zhang, HJ, 2018) |
| "The study included 28 men with late-onset hypogonadism (defined according to the criteria of the European Male Aging Study group) receiving testosterone undecanoate (120 mg in three equal doses), 12 of whom had been treated with oral metformin (1." | 4.02 | Hypothalamic-pituitary-gonadal axis and sexual functioning in metformin-treated men after discontinuation of testosterone replacement therapy: A pilot study. ( Kowalcze, K; Krysiak, R; Okopień, B, 2021) |
| "Men with type 2 diabetes (T2D) and obesity are often characterised by low testosterone (T)." | 1.48 | Short-term combined treatment with exenatide and metformin is superior to glimepiride combined metformin in improvement of serum testosterone levels in type 2 diabetic patients with obesity. ( Hao, M; Kuang, HY; Li, BW; Ma, XF; Pan, J; Shao, N; Wu, WH; Yu, XY; Yu, YM; Zhang, HJ, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krysiak, R | 1 |
| Kowalcze, K | 1 |
| Okopień, B | 1 |
| Shao, N | 1 |
| Yu, XY | 1 |
| Yu, YM | 1 |
| Li, BW | 1 |
| Pan, J | 1 |
| Wu, WH | 1 |
| Zhang, HJ | 1 |
| Ma, XF | 1 |
| Hao, M | 1 |
| Kuang, HY | 1 |
2 other studies available for metformin and Sexual Dysfunction, Physiological
| Article | Year |
|---|---|
Hypothalamic-pituitary-gonadal axis and sexual functioning in metformin-treated men after discontinuation of testosterone replacement therapy: A pilot study.
Topics: Adult; Aged; Blood Glucose; Gonadal Hormones; Gonadotropins; Hormone Replacement Therapy; Humans; Hy | 2021 |
Short-term combined treatment with exenatide and metformin is superior to glimepiride combined metformin in improvement of serum testosterone levels in type 2 diabetic patients with obesity.
Topics: Adult; Anti-Obesity Agents; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Drug Therapy, Com | 2018 |